The EPS projection of Ophthotech Corporation (NASDAQ:OPHT) for quarter ended 2016-09-30 is $-1.17. A week before, the EPS forecast was $-1.17 against target of $-1.17, a month earlier. This estimate stood at $-1.17 60 days earlier versus forecast of $-1.17 90 days earlier, confirming a deviation of 0%.
Ophthotech Corporation (NASDAQ:OPHT) reported that 18 days ago, the positive EPS revisions were 0 and negative revisions at 1.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 1, 2, 0 and 2, respectively.
The downgrade of EPS estimates for Ophthotech Corporation (NASDAQ:OPHT) in the preceding 120, 60, 30 and 90 days were 2, 2, 0 and 2, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of Ophthotech Corporation (NASDAQ:OPHT) was $-1.17. This projection was computed after accounting 5 calls. As reported on 2016-05-04 the EPS was $-1.03. The change was $0.29, demonstrating a percentage deviation of 21.97%. The projections confirmed a standard deviation of 0.12.
Quarterly Sales Estimates
For the fiscal 2016, the yearly sales target for Ophthotech Corporation (NASDAQ:OPHT) stands at $19.36 and the median estimate at $6.48. Almost 3 analysts announced their estimates.
The highest estimate is $49.5 while the lowest target is $2.1 showing standard deviation of 26.193%.
As many as 3 analysts released sales estimates reised in upside while 3 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 3 revised sales number projection on upside while 3 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 3 hiked sales estimations and 3 reduced sales forecast. Ophthotech Corporation (NASDAQ:OPHT) stated that the change in forecast was 0%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...